Korea Runs Three Reimbursement Speeds. September Shows All Three at Once.
The lane determines the timeline, and it is set long before you file. Model the Korean queue, not the approval date.
DealPulse Signal
The Beats
Analysis
The Briefs
Korea Runs Three Reimbursement Speeds. September Shows All Three at Once.
3 of 1,357 Cleared AI Devices Have Public Outcome Trials. The Study Has No Non-AI Comparator.
Biocon Makes It, a Consultancy Holds the Licence, and Sandoz Sells It
Abbott Cleared the First Dual Glucose and Ketone Sensor. FDA Judged Accuracy, Not Admissions.
This Money Buys Equipment, Not Operations. Your 2031 Answer Decides the 2027 Deal.